Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 2:23 pm Purchase |
2022-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
TCG Crossover GP I, LLC | 5,905,400 6.200% |
5,905,400 (New Position) |
Filing History |
| 2023-02-14 2:23 pm Purchase |
2022-12-31 | 13G | Silence Therapeutics plc SLN |
TCG Crossover GP I, LLC | 6,314,625 5.900% |
6,314,625 (New Position) |
Filing History |
| 2023-02-14 2:23 pm Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover GP I, LLC | 983,610 2.400% |
983,610 (New Position) |
Filing History |
| 2023-01-09 4:19 pm Purchase |
2022-12-28 | 13D | KalVista Pharmaceuticals, Inc. KALV |
TCG Crossover GP I, LLC | 3,408,081 9.900% |
3,408,081 (New Position) |
Filing History |